Clinical Conversations: The Choice of Adrenaline Injectors – A Practical Approach for GPs | Part One

Maria Said AM

writer

Maria Said AM

Registered Nurse; CEO of Allergy & Anaphylaxis Australia; Associate member of the Australasian Society of Clinical Immunology and Allergy

Maria Said AM

 

Two adrenalin injectors are now available and this allows the patients a choice, but GPs need to be familiar with both devices. RN Maria Said, the CEO of Allergy and Anaphylaxis Australia, discusses the devices and issues concerning the prescription and use of adrenaline injectors. This is a three-part article.

This is part one of a three part series.
Read part two
Read part three

Practice points

• The Epipen® has two strengths, a 150 ug dose for 7.5 kg to 20 kg and a 300 ug dose for over 20 kg according to ASCIA guidelines.
• The Anapen®has three strengths, 150 ug dose for 10 kg to 20 kg, a 300ug dose for 20 kg to 50 kg and the ASCIA prescription guidelines say that the 500 ug dose of Anapen® is for anyone weighing 50 kg and over.
• Anyone weighing more than 50 kg can be prescribed either the 300 ug dose of Epipen® or the 500 ug dose of Anapen®.
• Both the 150 ug dose of Epipen® and Anapen® have green labelling, both the 300 ug dose of Epipen® and 300ug dose of Anapen® have a bright yellow labelling and as there is no equivalent of 500 ug for Epipen®, the 500 ug Anapen® colouring is magenta.
• After use, the Anapen® will have the needle exposed so care is needed with where it is put.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jo-Ann See

Dr Jo-Ann See

Management of Acne in Teens

Dr Robert Hungerford

Dr Robert Hungerford

An Update on Heart Failure in General Practice

Dr Michael Selby

Dr Michael Selby

Scoliosis in Children: Preventing Surgery

A/Prof Yvonne Zissiadis

A/Prof Yvonne Zissiadis

Innovations in Breast Radiation

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Maria Said AM

writer

Maria Said AM

Registered Nurse; CEO of Allergy & Anaphylaxis Australia; Associate member of the Australasian Society of Clinical Immunology and Allergy

Test your knowledge

Recent articles

Latest GP poll

AHPRA's new CEO says he is committed to improving how complaints are handled. How likely is this to succeed?

Likely to succeed

0%

Unlikely to succeed

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

I invite you to join the upcoming Healthed webcast where I will give an update on current radiation therapy regimens and the potential side effects of this treatment. In addition, I will present the latest learnings from breast cancer research, including the increasing recognition of the value of exercise as part of effective breast cancer management.

Tuesday 5th August, 7pm AEST